Demonstrates that while N-linked glycosylation of the MHVR N-terminal domain is not required for mouse hepatitis virus receptor activity, a glycoprotein longer than the N-terminal domain is necessary.
Answers are grounded in this paper and cite their sources.
Informs minimal receptor requirements for coronaviruses; leaves open validation in human cells and in vivo models.
Mouse hepatitis virus binds to the N-terminal domain of its receptor, MHVR, a murine biliary glycoprotein with four immunoglobulin-like domains (G.S. Dveksler, M. N. Pensiero, C. W. Dieffenbach, C. B. Cardellichio, A.A. Basile, P.E. Elia, and K. V. Holmes, Proc. Natl. Acad. Sci. USA 90:1716-1720, 1993). A recombinant protein with only the anchored N-terminal domain was not a functional receptor, but a recombinant protein with the N-terminal domain of MHVR linked to the second and third immunoglobulin-like domains and anchor from the mouse poliovirus receptor homolog, mph, was a functional receptor for mouse hepatitis virus. The native four-domain MHVR has 16 potential N-linked glycosylation sites, including three on the N-terminal domain. Recombinant proteins lacking each one of these three sites or all three of them were functional receptors. Thus, glycosylation of the N-terminal domain is not required, but a glycoprotein longer than the N-terminal domain is required for virus receptor activity.
No takes yet. Share an insight, caveat, or question.
Dveksler et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: